Knöpfli, S.; Goeschl, B.; Zeyda, M.; Baghdasaryan, A.; Baumgartner-Kaut, M.; Baumgartner, M.R.; Herle, M.; Margreitter, J.; Poms, M.; Wortmann, S.B.;
et al. The Benefit of Detecting Reduced Intracellular B12 Activity through Newborn Screening Remains Unclear. Int. J. Neonatal Screen. 2024, 10, 40.
https://doi.org/10.3390/ijns10020040
AMA Style
Knöpfli S, Goeschl B, Zeyda M, Baghdasaryan A, Baumgartner-Kaut M, Baumgartner MR, Herle M, Margreitter J, Poms M, Wortmann SB,
et al. The Benefit of Detecting Reduced Intracellular B12 Activity through Newborn Screening Remains Unclear. International Journal of Neonatal Screening. 2024; 10(2):40.
https://doi.org/10.3390/ijns10020040
Chicago/Turabian Style
Knöpfli, Stella, Bernadette Goeschl, Maximilian Zeyda, Anna Baghdasaryan, Margot Baumgartner-Kaut, Matthias R. Baumgartner, Marion Herle, Julian Margreitter, Martin Poms, Saskia B. Wortmann,
and et al. 2024. "The Benefit of Detecting Reduced Intracellular B12 Activity through Newborn Screening Remains Unclear" International Journal of Neonatal Screening 10, no. 2: 40.
https://doi.org/10.3390/ijns10020040
APA Style
Knöpfli, S., Goeschl, B., Zeyda, M., Baghdasaryan, A., Baumgartner-Kaut, M., Baumgartner, M. R., Herle, M., Margreitter, J., Poms, M., Wortmann, S. B., Konstantopoulou, V., & Huemer, M.
(2024). The Benefit of Detecting Reduced Intracellular B12 Activity through Newborn Screening Remains Unclear. International Journal of Neonatal Screening, 10(2), 40.
https://doi.org/10.3390/ijns10020040